Clinical Trials on Gynaecological Malignancies
Total 1558 results
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Gastrointestinal MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
Geron CorporationCompletedSolid Tumor MalignanciesUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Solid MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnAdvanced Nonhematologic MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
Mayo ClinicGlaxoSmithKlineCompletedAdvanced Solid MalignanciesUnited States
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdNot yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Gilead SciencesRecruiting
-
Beijing Mabworks Biotech Co., Ltd.Recruiting
-
BeiGeneEnrolling by invitationAdvanced MalignanciesChina, Taiwan, Korea, Republic of, Turkey
-
Incyte CorporationTerminatedAdvanced MalignanciesUnited States, Italy, Denmark, Japan
-
University Medical Center GroningenTerminatedMetastatic MalignanciesNetherlands
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Clover Biopharmaceuticals AUS Pty LtdCompletedPeritoneal MalignanciesAustralia
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedAdvanced MalignanciesJapan
-
R-PharmCompletedSolid MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced MalignanciesUnited States
-
Southwest Hospital, ChinaUnknown
-
Infinity Pharmaceuticals, Inc.Terminated
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
University of KentuckyArno TherapeuticsCompleted
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesUnited States
-
Sigma-Tau Research, Inc.Dana-Farber Cancer Institute; Rhode Island HospitalCompletedSolid MalignanciesUnited States
-
Heidelberg Pharma AGUnited States Department of DefenseCompletedAdvanced MalignanciesUnited States
-
Medical College of WisconsinCompletedMalignancies, HematologicUnited States
-
Shanghai Tongji Hospital, Tongji University School...Recruiting
-
University of PittsburghAmerican College of Radiation OncologyRecruitingUpper Abdominal MalignanciesUnited States
-
Shenzhen Geno-Immune Medical InstituteRecruiting
-
Shenzhen Geno-Immune Medical InstituteRecruiting
-
Athenex, Inc.RecruitingAdvanced Solid MalignanciesUnited States
-
Novartis PharmaceuticalsActive, not recruitingALK Positive MalignanciesChina, United States, Italy, Taiwan, Australia, Belgium, Germany, Spain, Czechia, Japan, Russian Federation, Korea, Republic of, Hong Kong, France, Lebanon, Malaysia, Brazil, Poland, Bulgaria, Colombia, Singapore
-
Incyte CorporationActive, not recruitingB-cell MalignanciesUnited States
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
Gilead SciencesActive, not recruitingB-cell MalignanciesUnited States, United Kingdom, France
-
BeiGeneCompletedB-cell MalignanciesAustralia
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesFrance, Spain, Canada
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
Taipei Medical UniversityCompletedAdvanced Solid MalignanciesTaiwan
-
Summa Health SystemTerminatedAdvanced Bulky MalignanciesUnited States
-
Synta Pharmaceuticals Corp.CompletedSolid Tumor MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
Hanmi Pharmaceutical Company LimitedCompletedAdvanced Solid MalignanciesKorea, Republic of
-
AstraZenecaCompleted10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid MalignanciesAdvanced Solid MalignanciesChina